SBC Medical Group Holdings Incorporated (SBC)

NGM – Real Time Price. Currency in USD

3.31

+0.15 (4.75%)

At close: May 12, 2026, 4:00 PM EDT

01.05.2026

SBC Medical to Announce 1Q 2026 Financial Results

IRVINE, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced it will release its financial results for the first quarter ended March 31, 2026, before U.S. market open on May 14, 2026.

27.04.2026

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

IRVINE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced a comprehensive initiative to enhance English-speaking inbound customer support at Shonan Beauty Clinic.

22.04.2026

Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

NEW YORK CITY, NY / ACCESS Newswire / April 22, 2026 / Emerging Growth Research today announced the release of a Flash Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), reiterating its Buy-Extended rating and maintaining its 12-month price target of $9.00, representing potential upside from the Company's recent share price of $3.65 as of April 21, 2026. The Flash Report provides an update following recent share price volatility tied to a secondary share transaction, while reaffirming the Company's long-term growth outlook and underlying fundamentals.

21.04.2026

SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock

IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“the Company”), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the closing of its previously announced underwritten secondary public offering of 3,100,000 shares of the Company's common stock by Dr. Yoshiyuki Aikawa (the “Selling Stockholder”) at the public offering price of $3.25 per share. The proceeds from the offering to the.

19.04.2026

SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock

IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“the Company”), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the pricing of the underwritten secondary public offering of 3,100,000 shares of the Company's common stock by Dr. Yoshiyuki Aikawa (the “Selling Stockholder”) at the public offering price of $3.25 per share. Additionally, the Selling Stockholder has granted the unde.

06.04.2026

Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update

NEW YORK CITY, NY / ACCESS Newswire / April 6, 2026 / Emerging Growth Research today announced the release of its Quarterly Update Report on SBC Medical Group Holdings, Inc. (Nasdaq:SBC), reiterating a Buy-Extended rating and maintaining its 12-month price target of $9.00, representing potential upside from the Company's closing price of $4.47 on April 3, 2026. The Quarterly Update reflects SBC's Q4:25 financial results, ongoing business transition, and outlook for a return to revenue growth in 2026 following pricing-related headwinds experienced during 2025.

31.03.2026

PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- PRISM MarketView today published an exclusive Q&A feature with Yoshiyuki Aikawa, Chairman and Chief Executive Officer of SBC Medical Group Holdings (Nasdaq: SBC), a Japan-based management services organization building a large and growing global aesthetic medical network. In the interview, Aikawa discusses SBC Medical's evolution from a domestic platform into a globally scalable model, as well as the company's recent operational inflection, U.S. market entry, and long-term growth strategy.

Videos

No Data

There is no data to display

Press releases

27.04.2026

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

22.04.2026

Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

21.04.2026

SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock

19.04.2026

SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock

IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“the Company”), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the pricing of the underwritten secondary public offering of 3,100,000 shares of the Company's common stock by Dr. Yoshiyuki Aikawa (the “Selling Stockholder”) at the public offering price of $3.25 per share. Additionally, the Selling Stockholder has granted the unde.

SBC Medical Group Holdings Incorporated (SBC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

SBC Medical Group Holdings Incorporated (SBC)

SBC Medical to Announce 1Q 2026 Financial Results

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock

SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock

Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update

PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics

Videos

No Data

Press releases

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock

SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock

SBC Medical to Announce 1Q 2026 Financial Results

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock

SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock

Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update

PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics

Videos

No Data

Press releases

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock

SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock

Search stocks

SBC Medical Group Holdings Incorporated (SBC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

SBC Medical Group Holdings Incorporated (SBC)

SBC Medical to Announce 1Q 2026 Financial Results

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock

SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock

Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update

PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics

Videos

No Data

Press releases

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock

SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock

SBC Medical to Announce 1Q 2026 Financial Results

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock

SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock

Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update

PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics

Videos

No Data

Press releases

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock

SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock